ATE159658T1 - Verfahren und zusammensetzungen zur verabreichung von lipophilen heilmitteln in einer dosierung nach der gewünschten wirkung - Google Patents

Verfahren und zusammensetzungen zur verabreichung von lipophilen heilmitteln in einer dosierung nach der gewünschten wirkung

Info

Publication number
ATE159658T1
ATE159658T1 AT90902584T AT90902584T ATE159658T1 AT E159658 T1 ATE159658 T1 AT E159658T1 AT 90902584 T AT90902584 T AT 90902584T AT 90902584 T AT90902584 T AT 90902584T AT E159658 T1 ATE159658 T1 AT E159658T1
Authority
AT
Austria
Prior art keywords
patient
lipophilic
lollipop
compositions
desired effect
Prior art date
Application number
AT90902584T
Other languages
English (en)
Inventor
Theodore H Stanley
Brian Hague
Original Assignee
Univ Utah Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Utah Research Inst filed Critical Univ Utah Research Inst
Application granted granted Critical
Publication of ATE159658T1 publication Critical patent/ATE159658T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
AT90902584T 1989-09-05 1989-09-05 Verfahren und zusammensetzungen zur verabreichung von lipophilen heilmitteln in einer dosierung nach der gewünschten wirkung ATE159658T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/003801 WO1991003233A1 (en) 1989-09-05 1989-09-05 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs

Publications (1)

Publication Number Publication Date
ATE159658T1 true ATE159658T1 (de) 1997-11-15

Family

ID=22215208

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90902584T ATE159658T1 (de) 1989-09-05 1989-09-05 Verfahren und zusammensetzungen zur verabreichung von lipophilen heilmitteln in einer dosierung nach der gewünschten wirkung

Country Status (8)

Country Link
EP (1) EP0493380B1 (de)
JP (1) JP2758985B2 (de)
AT (1) ATE159658T1 (de)
AU (2) AU645966B2 (de)
DE (1) DE68928415T2 (de)
DK (1) DK175773B1 (de)
NO (2) NO920854L (de)
WO (1) WO1991003233A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH624011A5 (de) * 1977-08-05 1981-07-15 Battelle Memorial Institute
DE69635007T2 (de) * 1995-05-11 2006-06-01 University Of Utah Research Foundation, Salt Lake City Tabakersatz
US20060051413A1 (en) * 2004-09-08 2006-03-09 Chow Sing S M Method of enhancing absorptions of transmucosal administration formulations
EP1983827A4 (de) * 2006-02-01 2013-07-10 Stuart L Weg Verwendung von antifungalen zusammensetzungen für die behandlung von erkrankungen des oberen magen-darm-trakts
US20160022643A1 (en) * 2014-07-22 2016-01-28 Professional Compounding Centers Of America Oral Transmucosal Compositions including Aromatase Inhibitors for Low Testosterone Levels in Men
EP3200764B1 (de) * 2014-10-01 2020-07-22 Oxytone Bioscience B.V. Im mund zerfallende feste pharmazeutische dosiereinheit mit partuskontrollsubstanz
US10525099B2 (en) 2014-10-01 2020-01-07 Oxytone Bioscience B.V. Orally disintegrating solid pharmaceutical dosage unit containing a partus control substance
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
AU2020257625A1 (en) 2019-04-17 2021-11-04 Compass Pathfinder Limited Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2208120A (en) * 1938-03-02 1940-07-16 William B Coleman Pharmaceutical preparation and method of making same
US3943928A (en) * 1974-09-25 1976-03-16 Lariccia Anthony H Eliminating the safety hazard in oral dissolution of a solid
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
US4551329A (en) * 1984-01-20 1985-11-05 Joan Harris Oral medicament lollipop
US4671953A (en) * 1985-05-01 1987-06-09 University Of Utah Research Foundation Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics

Also Published As

Publication number Publication date
JPH05501854A (ja) 1993-04-08
DK175773B1 (da) 2005-02-14
DK30092D0 (da) 1992-03-05
NO920854L (no) 1992-04-27
AU645966B2 (en) 1994-02-03
DE68928415D1 (de) 1997-12-04
EP0493380A1 (de) 1992-07-08
AU6069794A (en) 1994-06-23
DE68928415T2 (de) 1998-02-26
NO920855D0 (no) 1992-03-04
DK30092A (da) 1992-05-05
EP0493380B1 (de) 1997-10-29
WO1991003233A1 (en) 1991-03-21
NO920854D0 (no) 1992-03-04
EP0493380A4 (en) 1992-10-07
AU5035290A (en) 1991-04-08
NO920855L (no) 1992-04-10
JP2758985B2 (ja) 1998-05-28

Similar Documents

Publication Publication Date Title
Reves et al. Comparison of two benzodiazepines for anaesthesia induction: midazolam and diazepam
DE69822665T2 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
Kennedy et al. Intravenous regional analgesia: an appraisal
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
ATE17079T1 (de) Praeparat zur behandlung von wunden der hautoberflaeche und verfahren zur herstellung des praeparats.
NO891379L (no) Anestetisk hudfuktingspreparat og fremgangsmaate for fremstilling derav.
HK18695A (en) Inhalation medicaments for treating respiratory disorders
Kesteloot et al. Clinical experience with lorcainide (R 15 889), a new anti-arrhythmic drug
CA2070685C (en) Method for treating painful, inflammatory or allergic disorders
GB2235626B (en) Inhalation medicaments for treating respiratory disorders
ATE159658T1 (de) Verfahren und zusammensetzungen zur verabreichung von lipophilen heilmitteln in einer dosierung nach der gewünschten wirkung
DE58901002D1 (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
ATE198550T1 (de) Verwendung von weihrauch zur behandlung der alzheimer-krankheit
ATE89737T1 (de) Behandlung von leukozytstoerungen mit gm-csf.
Yaacob et al. The efficacy of xylocaine topical anaesthetic in reducing injection pain
Sugai et al. Sequential changes in the fade of tetanic tension after the administration of tubocurarine in anaesthetized man
ATE224727T1 (de) Faktor xiii zur behandlung von hautwunden
EP0397211A3 (de) Perkutane Verabreichung von 3'-Azido-3'-Deoxythymidin
Reynolds et al. Circulatory versus respiratory deaths from pentothal sodium
RU94018748A (ru) Лекарственный сбор для лечения больных с нарушениями сердечного ритма
Suresh et al. Surgery in Siddha System
CN2233753Y (zh) 护心袋
Samuels et al. Regional anesthesia for the emergency department physician
RU93034329A (ru) Лекарственный сбор для лечения желудочковой экстрасистолии
姚尊华 et al. OBSERVATION ON 52 CASES OF PARALYSIS OF COMMON PERONEAL NERVE TREATED BY ACUPUNCTURE AND PLUM-BLOSSOM NEEDLING

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties